SEC Info - Natus Medical Inc - ‘8-K’ for 9/22/16

SEC Info℠

Home

Help

Please Sign In

Natus Medical Inc – ‘8-K’ for 9/22/16

On: Wednesday, 9/21/16, at 9:01pm ET · As of: 9/22/16 · For: 9/22/16 · Accession #: 878526-16-191 · File #: 0-33001

  As Of                Filer                Filing    For·On·As Docs:Size

 9/22/16  Natus Medical Inc                 8-K:5       9/22/16    2:53K

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     18K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML      8K

8-K — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 22, 2016

Natus Medical Incorporated

(Exact name of registrant as specified in its charter)



Delaware	000-33001	77-0154833
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

6701 Koll Center Parkway Suite 120 Pleasanton, CA 94566

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (925) 223-6700

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):



¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)



¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))



¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



ITEM 5.02.	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On September 22, 2016, Natus Medical Incorporated (the "Company") issued a press release announcing the appointment of Barbara R. Paul, M.D. as a member of its Board of Directors.

As a non-employee director, Dr. Paul's compensation consists of a grant of 3,360 Restricted Stock Units per the Company's 2011 Stock Award Plan. The award will vest on September 21, 2017. Dr. Paul will also receive cash compensation of $45,000 pursuant to the Company's board compensation plan.



Item 9.01.	Financial Statements and Exhibits

(d) Exhibits.



Exhibit No.		Description
99.1		Press release dated September 22, 2016 announcing the appointment of Barbara R. Paul, M.D. as a member of the Board of Directors.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.




		NATUS MEDICAL INCORPORATED

Date: September 22, 2016	By:	/s/ *Jonathan A. Kennedy*
		Jonathan A. Kennedy
		Senior Vice President Finance & Chief Financial Officer

Exhibit Index



Exhibit No.		Description
99.1		Press release dated September 22, 2016 announcing the appointment of Barbara R. Paul, M.D. as a member of the Board of Directors.

Dates Referenced Herein

This ‘8-K’ Filing	Date	Other Filings

	9/21/17	None on these Dates
Filed as of / For Period End:	9/22/16
Filed on:	9/21/16
		List all Filings

↑Top

Filing Submission 0000878526-16-000191 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)